High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale

Deborah A Williamson; Stefan Monecke; Helen Heffernan; Stephen R Ritchie; Sally A Roberts; Arlo Upton; Mark G Thomas; John D Fraser

doi:10.1093/cid/ciu658

High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale

Clin Infect Dis. 2014 Nov 15;59(10):1451-4. doi: 10.1093/cid/ciu658. Epub 2014 Aug 18.

Authors

Deborah A Williamson¹, Stefan Monecke², Helen Heffernan³, Stephen R Ritchie⁴, Sally A Roberts⁵, Arlo Upton⁶, Mark G Thomas⁴, John D Fraser⁷

Affiliations

¹ Department of Molecular Medicine and Pathology, University of Auckland Institute of Environmental Science and Research, Wellington Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.
² Alere Technologies, Jena Institute for Medical Microbiology and Hygiene, Dresden, Germany.
³ Institute of Environmental Science and Research, Wellington.
⁴ Department of Molecular Medicine and Pathology, University of Auckland.
⁵ Department of Clinical Microbiology, Auckland District Health Board.
⁶ LabTests Auckland, New Zealand.
⁷ Department of Molecular Medicine and Pathology, University of Auckland Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, New Zealand.

PMID: 25139961
DOI: 10.1093/cid/ciu658

Abstract

Our aim was to assess national prescribing trends and determine longitudinal resistance patterns for topical antimicrobials in New Zealand. We observed a dramatic increase in fusidic acid (FA) resistance, and clonal expansion of FA-resistant Staphylococcus aureus. This increase was concurrent with a significant national increase in topical FA dispensing.

Keywords: MRSA; antimicrobial resistance; antimicrobial use; epidemiology; fusC.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Administration, Topical
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / therapeutic use*
Drug Prescriptions / statistics & numerical data*
Drug Resistance, Bacterial*
Fusidic Acid / administration & dosage
Fusidic Acid / therapeutic use*
Humans
New Zealand
Staphylococcal Infections / drug therapy*
Staphylococcal Infections / microbiology
Staphylococcus aureus / drug effects*

Substances

Anti-Bacterial Agents
Fusidic Acid